After confirming plans for the Houston-area facility last year, a Taiwanese manufacturer has already filed plans for a third phase. Here's what it will involve.
A series of trial failures involving its depression drug have led Neumora Therapeutics Inc. to set that work aside and lay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results